Cargando…
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
Natural Killer (NK) cell dysfunction is associated with poorer clinical outcome in cancer patients. What regulates NK cell dysfunction in tumor microenvironment is not well understood. Here, we demonstrate that the human tumor-derived NKG2D ligand soluble MIC (sMIC) reprograms NK cell to secrete pro...
Autores principales: | Dhar, Payal, Basher, Fahmin, Ji, Zhe, Huang, Lei, Qin, Si, Wainwright, Derek A., Robinson, Jerid, Hagler, Shaye, Zhou, Jing, MacKay, Sean, Wu, Jennifer D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298432/ https://www.ncbi.nlm.nih.gov/pubmed/34294876 http://dx.doi.org/10.1038/s42003-021-02440-3 |
Ejemplares similares
-
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
por: Basher, Fahmin, et al.
Publicado: (2020) -
Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
por: Basher, Fahmin, et al.
Publicado: (2015) -
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC(+) tumors respond to PD1/PD-L1 blockade therapy
por: Zhang, Jinyu, et al.
Publicado: (2019) -
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
por: Zhang, Jinyu, et al.
Publicado: (2015) -
A nucleation barrier spring-loads the CBM signalosome for binary activation
por: Rodriguez Gama, Alejandro, et al.
Publicado: (2022)